Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (91-100 of 861) with videos related to

Pageof 87
Sort By:
Plos One|March 11, 2011
Neurite outgrowth mediated by translation elongation factor eEF1A1: a target for antiplatelet agent cilostazolKenji Hashimoto, Tamaki Ishima
Neuropharmacology|March 8, 2023
Ketamine and its metabolites: Potential as novel treatments for depressionKenji Hashimoto, Shigeyuki Chaki
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|June 8, 2002
[Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor]Kenji Hashimoto, Masaomi Iyo
Advances in Experimental Medicine and Biology|March 19, 2017
Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric DisordersYakup Albayrak, Kenji Hashimoto
Journal of Neurophysiology|February 1, 2008
Serotonin activates presynaptic and postsynaptic receptors in rat globus pallidusKenji Hashimoto, Hitoshi Kita
Current Pharmaceutical Design|November 1, 2006
Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticalsKenji Hashimoto, Kiichi Ishiwata
Biological Psychiatry|December 19, 2012
Reply to: Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamineAkira Kishimoto, Kenji Hashimoto
Biological Psychiatry|December 15, 2018
Lack of Opioid System in the Antidepressant Actions of KetamineKai Zhang, Kenji Hashimoto
Neuropsychopharmacology Reports|August 20, 2020
Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamineYuko Fujita, Kenji Hashimoto
The Journal of Clinical Psychiatry|October 29, 2025
Racemic Ketamine vs Esketamine in Treatment-Resistant Depression: The Overlooked Role of ArketamineYunfei Tan, Kenji Hashimoto
Pageof 87

Showing results (91-100 of 861) with videos related to

Sort By:
Pageof 87
Plos One|March 11, 2011
Neurite outgrowth mediated by translation elongation factor eEF1A1: a target for antiplatelet agent cilostazolKenji Hashimoto, Tamaki Ishima
Neuropharmacology|March 8, 2023
Ketamine and its metabolites: Potential as novel treatments for depressionKenji Hashimoto, Shigeyuki Chaki
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|June 8, 2002
[Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor]Kenji Hashimoto, Masaomi Iyo
Advances in Experimental Medicine and Biology|March 19, 2017
Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric DisordersYakup Albayrak, Kenji Hashimoto
Journal of Neurophysiology|February 1, 2008
Serotonin activates presynaptic and postsynaptic receptors in rat globus pallidusKenji Hashimoto, Hitoshi Kita
Current Pharmaceutical Design|November 1, 2006
Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticalsKenji Hashimoto, Kiichi Ishiwata
Biological Psychiatry|December 19, 2012
Reply to: Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamineAkira Kishimoto, Kenji Hashimoto
Biological Psychiatry|December 15, 2018
Lack of Opioid System in the Antidepressant Actions of KetamineKai Zhang, Kenji Hashimoto
Neuropsychopharmacology Reports|August 20, 2020
Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamineYuko Fujita, Kenji Hashimoto
The Journal of Clinical Psychiatry|October 29, 2025
Racemic Ketamine vs Esketamine in Treatment-Resistant Depression: The Overlooked Role of ArketamineYunfei Tan, Kenji Hashimoto
Pageof 87